| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.93▼ | 2.96▼ | 2.96▼ | 3.06▼ | 3.45▼ |
| MA10 | 2.95▼ | 2.97▼ | 3.06▼ | 3.07▼ | 3.20▼ |
| MA20 | 2.96▼ | 3.05▼ | 3.04▼ | 3.44▼ | 2.70▲ |
| MA50 | 2.98▼ | 3.03▼ | 2.99▼ | 3.21▼ | 2.42▲ |
| MA100 | 3.06▼ | 2.99▼ | 3.20▼ | 2.70▲ | 12.51▼ |
| MA200 | 3.04▼ | 3.24▼ | 3.63▼ | 2.38▲ | 20.02▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.018▼ | -0.020▼ | -0.071▼ | 0.244▲ |
| RSI | 38.986▼ | 37.999▼ | 41.494▼ | 40.909▼ | 46.698▼ |
| STOCH | 26.786 | 9.971▼ | 11.725▼ | 35.838 | 52.558 |
| WILL %R | -68.750 | -93.590▼ | -93.590▼ | -86.957▼ | -69.388 |
| CCI | -162.188▼ | -91.762 | -90.484 | -59.664 | 8.617 |
|
Wednesday, November 12, 2025 05:17 AM
Simufilam advancing towards a clinical study expected to begin in H1 2026 for the potential treatment of TSC-related epilepsyFurther fortified ...
|
|
Wednesday, October 22, 2025 05:16 AM
The MarketWatch News Department was not involved in the creation of this content. AUSTIN, Texas, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a ...
|
|
Tuesday, October 21, 2025 05:00 PM
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Cassava Sciences, Inc. (NASDAQ: SAVA) breached their fiduciary duties to shareholders.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/11/25 | 3.15 | 3.20 | 2.90 | 2.94 | 1,244,369 |
| 12/11/25 | 3.13 | 3.30 | 2.92 | 3.26 | 1,757,900 |
| 11/11/25 | 3.12 | 3.12 | 2.97 | 3.11 | 670,800 |
| 10/11/25 | 3.04 | 3.10 | 2.89 | 3.03 | 758,400 |
| 07/11/25 | 2.87 | 2.97 | 2.79 | 2.96 | 814,400 |
| 06/11/25 | 3.03 | 3.06 | 2.90 | 2.96 | 717,600 |
| 05/11/25 | 2.97 | 3.05 | 2.92 | 3.05 | 865,100 |
| 04/11/25 | 3.12 | 3.15 | 2.96 | 2.96 | 841,300 |
| 03/11/25 | 3.30 | 3.32 | 3.05 | 3.19 | 942,800 |
| 31/10/25 | 3.28 | 3.32 | 3.11 | 3.26 | 1,438,700 |
|
|
||||
|
|
||||
|
|